RU2018124599A3 - - Google Patents

Download PDF

Info

Publication number
RU2018124599A3
RU2018124599A3 RU2018124599A RU2018124599A RU2018124599A3 RU 2018124599 A3 RU2018124599 A3 RU 2018124599A3 RU 2018124599 A RU2018124599 A RU 2018124599A RU 2018124599 A RU2018124599 A RU 2018124599A RU 2018124599 A3 RU2018124599 A3 RU 2018124599A3
Authority
RU
Russia
Application number
RU2018124599A
Other languages
Russian (ru)
Other versions
RU2018124599A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018124599A3 publication Critical patent/RU2018124599A3/ru
Publication of RU2018124599A publication Critical patent/RU2018124599A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RU2018124599A 2015-12-14 2015-12-14 Кристаллические формы аналогов хинолона и их солей RU2018124599A (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2015/065443 WO2017105382A1 (en) 2015-12-14 2015-12-14 Crystalline forms of quinolone analogs and their salts

Publications (2)

Publication Number Publication Date
RU2018124599A3 true RU2018124599A3 (cg-RX-API-DMAC7.html) 2020-01-16
RU2018124599A RU2018124599A (ru) 2020-01-16

Family

ID=59057173

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018124599A RU2018124599A (ru) 2015-12-14 2015-12-14 Кристаллические формы аналогов хинолона и их солей

Country Status (10)

Country Link
EP (2) EP4249072A3 (cg-RX-API-DMAC7.html)
JP (1) JP2018537486A (cg-RX-API-DMAC7.html)
KR (1) KR20180111797A (cg-RX-API-DMAC7.html)
CN (1) CN108699083A (cg-RX-API-DMAC7.html)
AU (2) AU2015417382A1 (cg-RX-API-DMAC7.html)
CA (2) CA3006502A1 (cg-RX-API-DMAC7.html)
ES (1) ES2959536T3 (cg-RX-API-DMAC7.html)
IL (1) IL260004A (cg-RX-API-DMAC7.html)
RU (1) RU2018124599A (cg-RX-API-DMAC7.html)
WO (1) WO2017105382A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119185322A (zh) 2015-11-20 2024-12-27 生华生物科技股份有限公司 用于治疗癌症的四环喹诺酮类似物组合疗法
EP3752149A4 (en) * 2018-02-15 2022-03-02 Senhwa Biosciences, Inc. QUINOLONE ANALOGUES AND THEIR SALTS, COMPOSITIONS AND METHODS OF USE
US12378245B2 (en) * 2019-02-11 2025-08-05 Phoenix Molecular Designs Crystalline forms of an RSK inhibitor
US20210046071A1 (en) * 2019-08-14 2021-02-18 Senhwa Biosciences, Inc. Tetracyclic compounds and their salts, compositions, and methods for their use
WO2021030686A1 (en) * 2019-08-14 2021-02-18 Senhwa Biosciences, Inc. Crystalline forms of quinoline analogs and salts thereof, compositions, and their methods for use
JP2020189888A (ja) * 2020-08-28 2020-11-26 センワ バイオサイエンシズ インコーポレイテッド キノロン類似体及びその塩の結晶形
CN118005653B (zh) * 2023-04-23 2024-12-10 信义核新(北京)生物科技有限公司 喹诺酮类似物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ553746A (en) * 2004-09-17 2010-06-25 Cylene Pharmaceuticals Inc Quinolone analogs as cell proliferation inhibitors
EP1926372A2 (en) * 2005-08-19 2008-06-04 Cylene Pharmaceuticals, Inc. HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
KR101601332B1 (ko) 2007-10-05 2016-03-08 센화 바이오사이언시즈 인코포레이티드 퀴놀론 유사체 및 이와 관련된 방법
WO2012123938A1 (en) * 2011-03-17 2012-09-20 Tel Hashomer Medical Research Infrastructure And Services Ltd. Quinolone analogs for treating autoimmune diseases
EP3074391B1 (en) * 2013-11-28 2019-07-31 Tel Hashomer Medical Research Infrastructure And Services Ltd. Rna polymerase i inhibitors and uses thereof

Also Published As

Publication number Publication date
CA3255938A1 (en) 2025-11-28
EP4249072A3 (en) 2023-10-25
JP2018537486A (ja) 2018-12-20
AU2015417382A1 (en) 2018-06-14
ES2959536T3 (es) 2024-02-26
WO2017105382A1 (en) 2017-06-22
KR20180111797A (ko) 2018-10-11
CA3006502A1 (en) 2017-06-22
IL260004A (en) 2018-07-31
EP3394070A1 (en) 2018-10-31
AU2021203085B2 (en) 2023-06-08
EP3394070A4 (en) 2019-05-08
RU2018124599A (ru) 2020-01-16
AU2021203085A1 (en) 2021-06-10
CN108699083A (zh) 2018-10-23
EP3394070B1 (en) 2023-08-02
EP3394070C0 (en) 2023-08-02
EP4249072A2 (en) 2023-09-27

Similar Documents

Publication Publication Date Title
BR112018004104A2 (cg-RX-API-DMAC7.html)
BR112018004114A2 (cg-RX-API-DMAC7.html)
BR112018002747A2 (cg-RX-API-DMAC7.html)
AU2022228198B1 (cg-RX-API-DMAC7.html)
CN303069721S (zh) 发动机左体
CN303065305S (zh) 收纳盒
CN303072204S (zh) 机动车尾灯
CN303071288S (zh) 指夹式脉搏血氧饱和度仪(300c)
CN303068629S (zh) 电动车车体下段(自由)
CN303065242S (zh) 文件柜(3)
CN303067001S (zh) 囍字烟盒(四)
BE2015C047I2 (cg-RX-API-DMAC7.html)
BE2015C044I2 (cg-RX-API-DMAC7.html)
BR0002874B1 (cg-RX-API-DMAC7.html)
BR0008158B1 (cg-RX-API-DMAC7.html)
BR0008132B1 (cg-RX-API-DMAC7.html)
BR0000695B1 (cg-RX-API-DMAC7.html)
BR0000126B1 (cg-RX-API-DMAC7.html)
BR0009649B1 (cg-RX-API-DMAC7.html)
BR0007834B1 (cg-RX-API-DMAC7.html)
BR0002402B1 (cg-RX-API-DMAC7.html)
BR0007747B1 (cg-RX-API-DMAC7.html)
BR0003208B1 (cg-RX-API-DMAC7.html)
BR0308832B1 (cg-RX-API-DMAC7.html)
BR0007468B1 (cg-RX-API-DMAC7.html)